scispace - formally typeset
L

Lei Zhang

Researcher at Peking University

Publications -  24
Citations -  3149

Lei Zhang is an academic researcher from Peking University. The author has contributed to research in topics: Cancer & Cell. The author has an hindex of 13, co-authored 23 publications receiving 1410 citations. Previous affiliations of Lei Zhang include Centre for Life.

Papers
More filters
Journal ArticleDOI

Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.

TL;DR: Deep single-cell RNA sequencing of tumor-infiltrating T cells in non-small-cell lung cancer identifies features associated with functional states and clinical outcome and provides a new approach for patient stratification.
Journal ArticleDOI

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer.

TL;DR: An integrated RNA-sequencing approach demonstrates that CXCL13+ TH1-like cells are preferentially enriched in microsatellite-instable tumours from patients with colorectal cancer, and IGFLR1 is identified as a co-stimulatory molecule.
Journal ArticleDOI

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.

TL;DR: This comprehensive analysis of key myeloid subsets in human and mouse identifies critical cellular interactions regulating tumor immunity and defines mechanisms underlying myeloids-targeted immunotherapies currently undergoing clinical testing.
Journal ArticleDOI

A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells.

TL;DR: A pan-cancer analysis of single myeloid cells from 210 patients across 15 human cancer types identified distinct features of TIMs across cancer types and suggested future avenues for rational, targeted immunotherapies.
Journal ArticleDOI

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer

TL;DR: The data demonstrate that the SdM-RT-PCR assay is an effective breast cancer profiling method that utilizes very small volumes and is compatible with Biobank and the identified 3-miRNA signature is a promising circulating biomarker for breast cancer diagnosis.